Omar A. Bazirgan

680 total citations
8 papers, 551 citations indexed

About

Omar A. Bazirgan is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Omar A. Bazirgan has authored 8 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Omar A. Bazirgan's work include Ubiquitin and proteasome pathways (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Omar A. Bazirgan is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Omar A. Bazirgan collaborates with scholars based in United States, France and Canada. Omar A. Bazirgan's co-authors include Francis J. McNally, Karen Perry McNally, Martin Srayko, Randolph Y. Hampton, Paul E. Mains, Dan Buster, Vaughn V. Smider, Peter G. Schultz, Ian A. Wilson and Wenli Yu and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Omar A. Bazirgan

8 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar A. Bazirgan United States 6 383 245 124 84 80 8 551
Bijan Etemad-Moghadam United States 13 539 1.4× 349 1.4× 34 0.3× 291 3.5× 329 4.1× 14 1.2k
Phuay‐Yee Goh Singapore 15 728 1.9× 500 2.0× 29 0.2× 34 0.4× 95 1.2× 18 1000
Monique van Straaten Germany 9 337 0.9× 161 0.7× 9 0.1× 96 1.1× 31 0.4× 16 495
Murielle Rocancourt France 10 430 1.1× 513 2.1× 16 0.1× 37 0.4× 18 0.2× 12 811
D J Fishkind United States 6 306 0.8× 284 1.2× 16 0.1× 113 1.3× 16 0.2× 9 638
Catarina Cunha-Santos Portugal 9 272 0.7× 59 0.2× 40 0.3× 69 0.8× 12 0.1× 13 390
Roger Ollo France 13 485 1.3× 53 0.2× 149 1.2× 168 2.0× 8 0.1× 14 686
Gökhan Tolun United States 14 862 2.3× 128 0.5× 33 0.3× 23 0.3× 8 0.1× 20 983
Julia Gilden United States 7 237 0.6× 172 0.7× 11 0.1× 84 1.0× 19 0.2× 11 460
Sabine Mazaleyrat United Kingdom 10 342 0.9× 104 0.4× 22 0.2× 70 0.8× 7 0.1× 10 500

Countries citing papers authored by Omar A. Bazirgan

Since Specialization
Citations

This map shows the geographic impact of Omar A. Bazirgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar A. Bazirgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar A. Bazirgan more than expected).

Fields of papers citing papers by Omar A. Bazirgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar A. Bazirgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar A. Bazirgan. The network helps show where Omar A. Bazirgan may publish in the future.

Co-authorship network of co-authors of Omar A. Bazirgan

This figure shows the co-authorship network connecting the top 25 collaborators of Omar A. Bazirgan. A scholar is included among the top collaborators of Omar A. Bazirgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar A. Bazirgan. Omar A. Bazirgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wang, Feng, Damian C. Ekiert, Insha Ahmad, et al.. (2013). Reshaping Antibody Diversity. Cell. 153(6). 1379–1393. 177 indexed citations
2.
Bentley, Cornelia A., et al.. (2013). Arrayed antibody library technology for therapeutic biologic discovery. Methods. 60(1). 91–98. 1 indexed citations
3.
Mao, Hongyuan, et al.. (2010). Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization. Nature Biotechnology. 28(11). 1195–1202. 16 indexed citations
4.
Bazirgan, Omar A. & Randolph Y. Hampton. (2008). Cue1p Is an Activator of Ubc7p E2 Activity in Vitro and in Vivo. Journal of Biological Chemistry. 283(19). 12797–12810. 52 indexed citations
5.
Bazirgan, Omar A., Renee M. Garza, & Randolph Y. Hampton. (2006). Determinants of RING-E2 Fidelity for Hrd1p, a Membrane-anchored Ubiquitin Ligase. Journal of Biological Chemistry. 281(51). 38989–39001. 11 indexed citations
6.
Bazirgan, Omar A. & Randolph Y. Hampton. (2005). Cdc48–Ufd2–Rad23: the road less ubiquitinated?. Nature Cell Biology. 7(3). 207–209. 4 indexed citations
7.
McNally, Karen Perry, Omar A. Bazirgan, & Francis J. McNally. (2000). Two domains of p80 katanin regulate microtubule severing and spindle pole targeting by p60 katanin. Journal of Cell Science. 113(9). 1623–1633. 129 indexed citations
8.
Srayko, Martin, Dan Buster, Omar A. Bazirgan, Francis J. McNally, & Paul E. Mains. (2000). MEI-1/MEI-2 katanin-like microtubule severing activity is required for Caenorhabditis elegans meiosis. Genes & Development. 14(9). 1072–1084. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026